X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (1) 1
alpha (1) 1
anti-inflammatory agents - adverse effects (1) 1
anti-inflammatory agents - therapeutic use (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
blood sedimentation (1) 1
c-reactive protein - metabolism (1) 1
dosage and administration (1) 1
double-blind (1) 1
double-blind method (1) 1
drug therapy (1) 1
drug therapy, combination (1) 1
epidemiology (1) 1
female (1) 1
giant cell arteritis (1) 1
giant cell arteritis - blood (1) 1
giant cell arteritis - drug therapy (1) 1
glucocorticoids - therapeutic use (1) 1
humans (1) 1
infliximab (1) 1
interleukin-6 - blood (1) 1
male (1) 1
medicine, general & internal (1) 1
methotrexate (1) 1
monoclonal-antibody (1) 1
patient outcomes (1) 1
physiological aspects (1) 1
placebo (1) 1
polymyalgia-rheumatica (1) 1
prednisolone - therapeutic use (1) 1
prednisone - therapeutic use (1) 1
prognostic-factors (1) 1
remission induction (1) 1
secondary prevention (1) 1
temporal arteritis (1) 1
tumor necrosis factor-alpha - antagonists & inhibitors (1) 1
tumor-necrosis-factor (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 05/2007, Volume 146, Issue 9, p. 621
Background: Tumor necrosis factor-α is present in arteries in giant cell arteritis. Objective: To evaluate the efficacy of infliximab, an anti–tumor... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.